BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9381956)

  • 1. [Sertraline in the treatment of mixed anxiety and depression disorder].
    Carrasco JL; Díaz-Marsá M; Sáiz J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(3):141-5. PubMed ID: 9381956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
    Rabkin JG; Wagner G; Rabkin R
    J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline in the treatment of mixed anxiety and depression disorder.
    Carrasco JL; Díaz-Marsá M; Sáiz-Ruiz J
    J Affect Disord; 2000 Jul; 59(1):67-9. PubMed ID: 10814773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label pilot study of fluvoxamine for mixed anxiety-depression.
    Houck C
    Psychopharmacol Bull; 1998; 34(2):225-7. PubMed ID: 9641005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sertraline in the treatment of premenstrual dysphoric disorder.
    Yonkers KA; Halbreich U; Freeman E; Brown C; Pearlstein T
    Psychopharmacol Bull; 1996; 32(1):41-6. PubMed ID: 8927673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed anxiety-depression in a 1 year follow-up study: shift to other diagnoses or remission?
    Barkow K; Heun R; Wittchen HU; Bedirhan Ustün T; Gänsicke M; Maier W
    J Affect Disord; 2004 Apr; 79(1-3):235-9. PubMed ID: 15023500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF; Lane RM; Zhu R; Ying Z
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clorazepate on depressed mood in anxious patients.
    Zung WW
    J Clin Psychiatry; 1987 Jan; 48(1):13-4. PubMed ID: 2879832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale.
    Scott TF; Nussbaum P; McConnell H; Brill P
    Neurol Res; 1995 Dec; 17(6):421-2. PubMed ID: 8622794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline in children and adolescents with social anxiety disorder: an open trial.
    Compton SN; Grant PJ; Chrisman AK; Gammon PJ; Brown VL; March JS
    J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):564-71. PubMed ID: 11349701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder.
    Steiner M; Allgulander C; Ravindran A; Kosar H; Burt T; Austin C
    Hum Psychopharmacol; 2005 Jan; 20(1):3-13. PubMed ID: 15551351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
    Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B
    Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E; Garcia-Garcia M; Porras-Chavarino A
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
    Fava M; Nierenberg AA; Quitkin FM; Zisook S; Pearlstein T; Stone A; Rosenbaum JF
    Psychopharmacol Bull; 1997; 33(1):101-3. PubMed ID: 9133758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline treatment of elderly patients with depression and cognitive impairment.
    Devanand DP; Pelton GH; Marston K; Camacho Y; Roose SP; Stern Y; Sackeim HA
    Int J Geriatr Psychiatry; 2003 Feb; 18(2):123-30. PubMed ID: 12571820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.